Alpha Family Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpha Family Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$738K	Sell	1,485 -150	-9%	-$66.5K	0.3%	55
2026 Q1	$730K	Buy	1,635 +150	+10%	+$69.9K	0.35%	46
2025 Q4	$673K	Hold	1,485	–	–	0.31%	56
2025 Q3	$582K	Sell	1,485 -235	-14%	-$98.2K	0.27%	68
2025 Q2	$766K	Hold	1,720	–	–	0.38%	49
2025 Q1	$834K	Buy	1,720 +235	+16%	+$110K	0.49%	46
2024 Q4	$598K	Hold	1,485	–	–	0.34%	47
2024 Q3	$691K	Hold	1,485	–	–	0.39%	47
2024 Q2	$696K	Hold	1,485	–	–	0.41%	44
2024 Q1	$621K	Hold	1,485	–	–	0.38%	49
2023 Q4	$604K	Hold	1,485	–	–	0.41%	45
2023 Q3	$516K	Hold	1,485	–	–	0.39%	51
2023 Q2	$523K	Hold	1,485	–	–	0.36%	46
2023 Q1	$468K	Buy	+1,485	New	+$445K	0.37%	51

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Alpha Family Trust's VRTX Position: Q2 2026 in Review

Alpha Family Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 9.2% in Q2 2026, selling an estimated $66.5K and leaving 1,485 shares worth $738K. The position accounts for 0.3% of the portfolio, ranked #55.

Alpha Family Trust first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $834K in Q1 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Alpha Family Trust held 1,485 shares of Vertex Pharmaceuticals worth $738K as of Q2 2026.
Alpha Family Trust sold 150 Vertex Pharmaceuticals shares in Q2 2026, an estimated $66.5K.
Vertex Pharmaceuticals made up 0.3% of Alpha Family Trust's portfolio in Q2 2026, its #55 holding.
Alpha Family Trust first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Alpha Family Trust's Vertex Pharmaceuticals position peaked at $834K in Q1 2025.
1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Alpha Family Trust's 13F filing for Q2 2026, filed 10 Aug 2026.